|1.||Youdim, Moussa B H: 8 articles (06/2014 - 10/2004)|
|2.||Thase, Michael E: 6 articles (07/2012 - 01/2003)|
|3.||Marco-Contelles, José: 5 articles (07/2014 - 12/2011)|
|4.||Unzeta, Mercedes: 5 articles (06/2014 - 12/2011)|
|5.||Soriano, Elena: 4 articles (07/2014 - 01/2014)|
|6.||Samadi, Abdelouahid: 4 articles (06/2014 - 12/2011)|
|7.||Bar-Am, Orit: 4 articles (09/2012 - 10/2005)|
|8.||Fridkin, Mati: 4 articles (01/2010 - 10/2005)|
|9.||Zheng, Hailin: 4 articles (01/2010 - 10/2005)|
|10.||Petzer, Jacobus P: 3 articles (10/2015 - 01/2015)|
|1.||Panic Disorder (Panic Attack)
01/01/1989 - "Monoamine oxidase inhibitors are effective in the treatment of panic attacks. "
09/01/1992 - "Monoamine oxidase inhibitors may be particularly helpful in patients with panic disorder who exhibit social avoidance. "
03/01/1995 - "It is generally thought that atypical depression would respond better to monoamine oxidase inhibitors (MAOI), but it would seem that it is mainly major depression associated with panic disorder that could predict this kind of response to treatment. "
01/01/1992 - "The monoamine oxidase inhibitors have also proved very useful in the treatment of panic disorder and social phobia, but probably should be used only by physicians with experience with this type of medication."
01/01/1993 - "Monoamine oxidase (MAO) inhibitors are known to be effective in panic disorder, but a high incidence of adverse reactions have limited their use. "
|2.||Phobic Disorders (Phobia)
06/01/1994 - "Previous studies have shown selective and nonselective monoamine oxidase inhibitors (MAOIs) to be effective in the treatment of social phobia. "
12/01/2002 - "The efficacy of irreversible and reversible monoamine oxidase inhibitors (MAOIs) in the treatment of social phobia (SP) is well established. "
01/01/1999 - "Efficacy in social phobia was reported with the MAOIs and this led to the investigation of reversible inhibitors of monoamine oxidase-A (RIMA) which offer a safer alternative. "
04/01/1992 - "Overall, the findings support the responsivity of social phobia to monoamine oxidase inhibitors."
07/01/1984 - "Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification."
01/01/1988 - "Monoamine oxidase inhibitors (MAOI's) have been shown to be significantly superior to placebo in the treatment of some anxiety disorders, particularly agoraphobia and mixed anxiety--depressive states. "
12/01/1982 - "Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia."
03/01/1985 - "This article reviews the evidence on the efficacy of monoamine oxidase inhibitors (MAOIs) and of alprazolam in the treatment of panic disorder and agoraphobia. "
12/01/1982 - "The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors for the treatment of agoraphobia and other panic disorders is reviewed with an emphasis on controlled prospective studies. "
03/01/1985 - "Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia."
|4.||Bipolar Disorder (Mania)
07/01/2012 - "Monoamine oxidase inhibitors (MAOIs) have proven efficacy for treating depression, particularly in patients with atypical depression, high levels of anxiety, anergic bipolar depression, and treatment-resistant depression. "
01/01/2012 - "Monoamine oxidase inhibitors (MAOIs) have proven efficacy for treating depression and for decades have been a preferred treatment for patients with atypical depression, high levels of anxiety, anergic bipolar depression, and treatment-resistant depression. "
01/01/2000 - "Monoamine oxidase inhibitors should be considered for patients with anergic bipolar depression. "
01/01/1996 - "Monoamine oxidase inhibitors are the antidepressant of choice for atypical bipolar depression. "
01/01/1982 - "In a parallel fashion, most pharmacological agents are selectively effective in one mood phase (tricyclics and monoamine oxidase inhibitors for depression, and neuroleptics for mania) and frequently precipitate or exacerbate the opposite phase. "
|5.||Anxiety Disorders (Anxiety Disorder)
09/01/2012 - "Monoamine oxidase inhibitors (MAOIs) can be highly effective therapeutic agents for depression and some anxiety disorders. "
03/01/2012 - "Despite the fact that monoamine oxidase inhibitors (MAOIs) can be highly effective therapeutic agents for depression and some anxiety disorders, they tend to be underutilized in clinical practice. "
11/01/1989 - "Monoamine oxidase inhibitor (MAOI) drugs are used in the treatment of depressive and anxiety disorders in adults. "
10/01/1989 - "A total of 1269 psychiatrists, from 15 European countries, completed a questionnaire assessing treatment choice in depressive and anxiety disorders, with particular focus on diagnostic and other factors determining use of monoamine oxidase inhibitors (MAOIs). "
01/01/1988 - "Monoamine oxidase inhibitors in anxiety disorders."
|1.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|3.||Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
|4.||Antidepressive Agents (Antidepressants)
|5.||Monoamine Oxidase (MAO)
|9.||Serotonin (5 Hydroxytryptamine)
|10.||Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
|1.||Blood Pressure Monitors
|2.||Drug Therapy (Chemotherapy)